Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ATOS — Atossa Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,848
+$461 QoQ
Shares Held
1,994
+209.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 31 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ATOS ranks #336 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ATOS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,848 1,994
2026-03-31 $3,387 644
2025-12-31 $556 943
2025-09-30 $648 745
2025-06-30 $6,469 7,795
2025-03-31 $11,750 17,539
2024-12-31 $16,834 17,910
2024-09-30 $20,146 13,255
2024-06-30 $14,157 11,897
2024-03-31 $91 51
2023-12-31 $75 86
2023-09-30 $143 194
2023-06-30 $217 173
2023-03-31 $14 20
2022-06-30 $10 10
2022-03-31 $8,986 7,189
2021-12-31 $38,253 23,909
2021-09-30 $70,476 21,619
2021-06-30 $103,711 16,410
2021-03-31 $4,220 2,000